FIELD: medicine; pharmaceutics.
SUBSTANCE: group of inventions relates to the field of medicine, chemical-pharmaceutical industry and pharmacy, specifically to a pharmaceutical composition for oral administration, having antifungal activity, which can be used for treating and / or preventing candida infections, as well as to methods for preparing said composition in the form of tablets or hard gelatin capsules. Pharmaceutical composition contains as active substance 20.0–50.0 wt% 4,4,4-trichloro-1-(4-chlorophenyl)butane-1,3-dione and auxiliary substances – 40.0–70.0 wt% of microcrystalline cellulose, 5.0–15.0 wt% of starch, 3.0–10.0 wt% of polyvinylpyrrolidone, 1.0–10.0 wt% of disintegrant, 0.5–1.0 wt% stearic acid and / or a pharmaceutically acceptable salt thereof.
EFFECT: composition according to the invention, obtained by direct compression or encapsulation of various components, provides a high degree of release of the active substance, has sufficient mechanical strength, is characterized by high therapeutic activity, satisfactory processing characteristics and is stable during storage for at least 2 years.
9 cl, 2 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL ANTI-DIABETIC COMPOSITION BASED ON SUBSTITUTED THIOPHENE CARBOXYLATE AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2688235C1 |
PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
PHARMACEUTICAL COMPOSITION COMPRISING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, DOSAGE FORM BASED ON PHARMACEUTICAL COMPOSITION COMPRISING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARING AND USING DOSAGE FORM BASED ON PHARMACEUTICAL COMPOSITION CONTAINING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2021 |
|
RU2818092C1 |
PHARMACEUTICAL COMPOSITION OF MOXIFLOXACIN AND METHOD FOR PRODUCING IT | 2014 |
|
RU2558932C1 |
PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
FORMULATION OF COUGH MEDICAL COMPOSITION AND METHOD FOR PRODUCING IT | 2012 |
|
RU2550927C2 |
2-AMINOCHROMEN DERIVATIVES EXHIBITING ANTI-TUMOR ACTIVITY; PHARMACEUTICAL COMPOSITIONS | 2018 |
|
RU2704262C1 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF GASTRIC AND DUODENUM ULCER IN FORM OF SOLID GELATIN CAPSULES, WHICH CONTAINS RABEPRAZOLE OR ITS DERIVATIVES, AND METHOD OF ITS OBTAINING | 2007 |
|
RU2414889C2 |
DOSAGE FORM IN CAPSULE FORM CONTAINING TABLETS WITH DIMETHYL FUMARATE | 2019 |
|
RU2742745C1 |
DRUG BASED ON TETRAMETILTETRAAZOBITSIKLOOKTANDION AND METHOD FOR ITS PRODUCTION | 2012 |
|
RU2611194C2 |
Authors
Dates
2019-11-26—Published
2019-07-02—Filed